LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Uždarymo kaina

2.45 2.94

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.33

Max

2.51

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-77K -3.6M
Darbuotojai	20
EBITDA	-79K -3.6M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+213.81% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	26M 167M
Ankstesnė atidarymo kaina	-0.49
Ankstesnė uždarymo kaina	2.45

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-04 23:39; UTC

Karštos akcijos

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

2026-03-04 23:20; UTC

Uždarbis

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

2026-03-04 21:43; UTC

Uždarbis

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

2026-03-04 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise After Recent Selloffs -- Market Talk

2026-03-04 23:33; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

2026-03-04 23:24; UTC

Rinkos pokalbiai

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy 4Q EPS C$2.86 >VET

2026-03-04 22:04; UTC

Rinkos pokalbiai

RBA Slipping Behind The Curve On Rates -- Market Talk

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Rev $66.8M >LAC

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Loss/Shr 52c >LAC

2026-03-04 21:52; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:50; UTC

Uždarbis

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

2026-03-04 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q Rev $165.2M >BULL

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q EPS 1c >BULL

2026-03-04 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-04 21:45; UTC

Rinkos pokalbiai

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

2026-03-04 21:40; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:36; UTC

Svarbiausios naujienos

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

2026-03-04 21:27; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:17; UTC

Rinkos pokalbiai

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

2026-03-04 21:16; UTC

Uždarbis

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q EPS $1.50 >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Net $7.35B >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Rev $19.31B >AVGO

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

213.81% į viršų

12 mėnesių prognozė

Vidutinis 7.5 USD 213.81%

Aukščiausias 12 USD

Žemiausias 5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.